Renovo News
-
Renovo Group plc (LSE: RNVO), the biopharmaceutical company developing drugs for the reduction of scarring and acceleration of healing is pleased to announce, with immediate effect, the appointment...read more
-
TR-1: NOTIFICATION OF MAJOR INTERESTS IN SHARES 1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: Renovo Group plc 2....read more
-
Details of the RNS detailing the revised Shire licensing deal for Juvista can be viewed here ...read more
-
Details of the outcome of the 2010 AGM are here...read more
-
PRELIMINARY RESULTS NOTIFICATION ...read more
-
Ahead of its Annual General Meeting (AGM), which is being held today, Renovo Group plc (LSE: RNVO), the biopharmaceutical company developing drugs to reduce scarring, improve wound healing an...read more
-
Details of The Interim Management Statement for the period to 30 June 2010 realeased today may be viewed...read more